S&P 500
(-0.19%) 5 459.02 points
Dow Jones
(-0.35%) 38 975 points
Nasdaq
(0.07%) 17 730 points
Oil
(0.36%) $81.12
Gas
(-3.48%) $2.66
Gold
(-0.96%) $2 308.40
Silver
(-0.43%) $28.75
Platinum
(1.48%) $1 001.00
USD/EUR
(0.29%) $0.936
USD/NOK
(0.73%) $10.68
USD/GBP
(0.40%) $0.791
USD/RUB
(-0.07%) $87.43

リアルタイムの更新: Entasis Therapeutics [ETTX]

取引所: NASDAQ セクター: Healthcare 産業: Biotechnology
最終更新日時5 6月 2024 @ 05:00

0.00% $ 2.19

Live Chart Being Loaded With Signals

Commentary (5 6月 2024 @ 05:00):

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant pathogens in the United States...

Stats
本日の出来高 68 834
平均出来高 0
時価総額 0.00
EPS $-0.320 ( Q1 | 2022-04-27 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.950
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0320 (1.46%)
AADI -1.76%
ABCL 1.83%
ABCM 0.04%
ABEO -2.84%
ABIO -0.28%
ABOS -2.80%
ABSI 0.34%
ABUS -3.28%
ABVX -2.56%
ACAD -1.41%
ACER -17.95%
ACET -3.39%
ACGN 1.29%
ACHL -4.15%
ACHV -0.65%
ACIU -1.03%
ACLX -0.52%
ACRV -2.97%
ACST -1.95%
ACXP 0.36%
ADAG -3.08%
ADAP -2.30%
ADGI 0.87%
ADIL 0.88%
ADMA -2.54%
ADPT 0.74%
ADTX -4.81%
ADVM -2.60%
ADXN -1.60%
AEON -1.08%
AEZS -3.51%
AFMD -0.37%
AGEN -0.30%
AGIO -1.83%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -6.14%
AKRO -2.68%
AKTX 2.44%
AKUS 0.00%
ALBO 0.00%
ALDX -2.40%
ALEC -4.11%
ALGS -3.69%
ALKS -0.29%
ALLK -8.51%
ALLO -6.03%
ALLR -3.37%
ALNA 3.16%
ALNY 0.60%
ALPN 0.02%
ALPX 0.00%
ALRN -2.50%
ALT -9.63%
ALVR -2.67%
ALXN 0.00%
ALXO -9.57%
ALZN -2.05%
AMRN 1.63%
AMTI -3.13%
ANAB 0.13%
ANEB -4.55%
ANGN 0.00%
ANIX 0.00%
ANL -3.22%
ANNX -0.44%
ANPC -3.15%
APGE -1.37%
APGN 8.48%
APGNW 30.65%
APLM 0.66%
APLS -0.59%
APLT -4.96%
APM -1.26%
APOP 0.38%
APRE 2.29%
APTO 3.38%
APTX 3.17%
APVO 0.95%
ARAV -13.39%
ARCT -4.34%
ARDS -14.23%
ARDX -1.91%
ARGX -1.09%
ARNA 0.00%
ARPO -0.90%
ARQT -1.88%
ARTL -3.62%
ARTLW 0.00%
ARVN 3.25%
ARWR -3.12%
ASLN -1.80%
ASMB -1.23%
ASND -2.26%
ATAI -1.11%
ATHA 5.71%
ATHE 1.13%
ATHX -33.50%
ATNF 3.37%
ATOS 4.85%
ATRA -0.12%
ATXI 0.00%
ATXS -0.50%
AUPH -1.35%
AURA 1.03%
AUTL -0.58%
AVBP -1.83%
AVEO 0.00%
AVIR 0.44%
AVRO -1.41%
AVTE -3.11%
AVTX -1.25%
AVXL -2.96%
AXLA 0.00%
AXSM -2.06%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 0.94%
BCAB 4.58%
BCDA -1.55%
BCDAW -41.77%
BCEL 0.00%
BCLI 4.62%
BCRX -0.99%
BCTX 8.34%
BCTXW -16.29%
BCYC 0.17%
BDRX -1.78%
BDTX -1.28%
BEAM -1.15%
BFRA -2.91%
BGNE -2.58%
BIOR -3.34%
BIVI 0.20%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.45%
BLTE -0.62%
BLU 0.03%
BLUE -0.61%
BMEA -7.49%
BMRN -0.61%
BNOX -2.51%
BNTC -2.11%
BNTX -0.90%
BOLD -8.13%
BOLT -0.05%
BPMC -1.23%
BPTH 0.58%
BPTS -13.47%
BRNS 0.37%
BRTX -0.47%
BTAI 10.94%
BTTX 1.35%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 5.08%
CABA -2.08%
CADL 1.23%
CALA 0.00%
CALC 0.00%
CALT -0.67%
CAPR -3.64%
CARA 4.02%
CARM 2.59%
CASI -3.72%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -6.40%
CCCC -2.12%
CCXI 0.00%
CDAK 0.00%
CDIO -6.53%
CDIOW 24.00%
CDMO -1.83%
CDMOP 0.04%
CDT 0.00%
CDTTW -39.60%
CDTX -1.05%
CDXC -1.02%
CDXS 4.48%
CELC -3.24%
CELU -3.33%
CELUW 11.80%
CERC -1.68%
CERE -0.53%
CERO -5.39%
CEROW 0.60%
CFRX -27.95%
CGEM -4.60%
CGEN -2.20%
CGON -0.99%
CGTX -1.14%
CHMA -6.00%
CHRS 0.32%
CINC 0.00%
CING 2.37%
CINGW 34.95%
CKPT -2.88%
CLBS -16.75%
CLDX -3.50%
CLGN 0.60%
CLLS -4.14%
CLNN 2.42%
CLNNW 0.00%
CLRB 6.69%
CLSD -2.00%
CLSN -0.68%
CLVS 0.00%
CMMB 0.97%
CMND 4.84%
CMPI 0.00%
CMPX -3.76%
CMRA 0.00%
CMRAW 33.33%
CMRX -1.63%
CNCE 0.00%
CNSP -39.37%
CNST 0.00%
CNTA -0.34%
CNTB 2.26%
CNTX -3.65%
COCP -2.78%
COEPW 32.45%
COGT -3.13%
CORT 1.12%
COYA 1.79%
CPRX -0.79%
CRBP -1.89%
CRBU -4.60%
CRDF -3.32%
CRGX -0.44%
CRIS -0.38%
CRNX -5.01%
CRSP -0.20%
CRTX 2.63%
CRVO -0.10%
CRVS 2.80%
CSBR -1.59%
CTCX -11.35%
CTIC 0.06%
CTMX -1.65%
CTNM -0.80%
CTXR 5.95%
CUE 5.19%
CVAC 0.57%
CVKD 0.15%
CWBR 2.80%
CYAD -12.96%
CYCC 11.25%
CYCCP 5.49%
CYCN 1.50%
CYT -2.27%
CYTK -2.40%
CYTO -2.73%
DARE 3.31%
DAWN -1.64%
DBTX -0.81%
DBVT 0.91%
DFFN 10.28%
DICE 0.06%
DMAC 13.27%
DNLI -1.21%
DNTH -6.28%
DOMH -1.58%
DRMA -2.15%
DRMAW -1.25%
DRNA 0.00%
DRTS 4.63%
DRTSW 0.00%
DRUG -7.39%
DSGN -0.60%
DTIL 0.89%
DYAI 4.84%
EARS -1.77%
EDIT -2.92%
EDSA -1.00%
EFTR 8.93%
EFTRW -74.07%
EIGR -9.21%
ELAB -2.01%
ELDN 6.30%
ELEV -4.56%
ELOX 7.69%
ELTX -0.88%
ELVN -5.81%
ELYM -4.60%
ENGN 0.25%
ENGNW 0.12%
ENLV 2.53%
ENOB 1.79%
ENSC 5.77%
ENTA -0.35%
ENTO 1.66%
ENTX -1.10%
ENVB 1.41%
EPIX -0.72%
EPRX -2.97%
EPZM 0.00%
EQ 0.91%
EQRX -2.09%
EQRXW 0.00%
ERAS 0.96%
ERNA -0.96%
ERYP 1.30%
ESLA 4.37%
ESLAW 87.05%
ETNB -2.93%
ETON -0.30%
ETTX 0.00%
EVAX -2.56%
EVGN 0.58%
EVLO 0.00%
EWTX 0.00%
EXAI 0.47%
EXEL -0.45%
EYEG -0.69%
EYEN 4.58%
EYPT 0.12%
FATE -7.39%
FBIO 0.59%
FBIOP 0.32%
FBLG -6.00%
FBRX -6.12%
FDMT -4.09%
FENC -0.81%
FGEN -3.86%
FHTX 0.00%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -2.38%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.81%
FULC -4.52%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -6.01%
GANX -2.31%
GBIO -2.12%
GBT 0.01%
GDTC 0.50%
GERN -3.87%
GHRS -3.10%
GLMD 0.50%
GLPG -2.13%
GLSI 3.55%
GLTO -0.18%
GLUE -2.63%
GLYC -15.38%
GMAB -0.27%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -0.52%
GNLX 2.00%
GNPX 6.13%
GNTA 3.94%
GOSS -3.86%
GOVX -10.91%
GOVXW -49.04%
GPCR -4.58%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS 1.98%
GRTX 2.12%
GTHX 0.00%
GUTS -4.45%
GXGXW 41.67%
GYRE -0.81%
HALO -1.34%
HARP 0.09%
HCWB -7.81%
HEPA 2.80%
HGEN -84.62%
HILS 5.66%
HLVX 1.15%
HOOK 2.76%
HOTH -1.68%
HOWL -0.85%
HRMY -0.40%
HRTX 1.15%
HSTO 0.00%
HUMA 0.71%
HUMAW -0.01%
IBRX -5.46%
ICCC 0.22%
ICPT 0.21%
ICU 17.36%
ICUCW 20.20%
ICVX -0.91%
IDRA -23.04%
IDYA -1.41%
IFRX 0.00%
IGMS -0.59%
IKNA 0.00%
IKT 1.42%
IMAB -1.16%
IMCR -3.47%
IMGN 0.02%
IMGO 0.00%
IMMP 4.74%
IMMX -3.02%
IMNM -3.29%
IMNN 2.34%
IMPL -27.27%
IMRA 15.96%
IMRN 0.00%
IMRX -0.69%
IMTX -1.75%
IMTXW 6.00%
IMUX 1.81%
IMV 0.00%
IMVT -2.27%
INAB 0.77%
INBX -0.66%
INCY -1.23%
INDP 10.20%
INFI -52.38%
INKT 0.01%
INM -2.03%
INMB 0.00%
INO -4.14%
INSM -1.13%
INTS -1.47%
INVA 0.16%
INZY 0.69%
IOBT -8.86%
IONS -0.33%
IOVA -1.78%
IPA -0.27%
IPHA 5.58%
IPSC -0.59%
IRON -3.10%
ISEE 0.38%
ITOS -1.16%
ITRM 0.83%
IVA 6.96%
IVVD -1.24%
JAGX 0.01%
JANX -3.67%
JAZZ -1.19%
JNCE 0.00%
JSPR -6.55%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -5.34%
KALV -1.34%
KDNY 0.22%
KMPH -0.34%
KNSA -2.32%
KNTE -0.38%
KOD -6.32%
KPRX -0.47%
KPTI 0.46%
KRBP -10.00%
KRON 1.06%
KROS -1.27%
KRRO -3.57%
KRTX 0.03%
KRYS -1.12%
KTRA 10.45%
KTTA 8.16%
KTTAW 0.92%
KURA -1.76%
KYMR -2.99%
KYTX -5.88%
KZIA 7.66%
KZR -0.21%
LABP 0.57%
LBPH -1.23%
LBPS 0.00%
LBPSW 14.81%
LEGN 0.64%
LENZ -5.94%
LEXX -1.15%
LEXXW -14.63%
LGND -0.82%
LGNDV 0.00%
LGVN -8.97%
LIAN -8.28%
LIFE 2.70%
LIPO -6.55%
LIXT -3.77%
LIXTW 95.35%
LJPC -0.32%
LMNL 0.12%
LOGC 0.26%
LPCN -5.27%
LPTX 0.00%
LQDA -0.73%
LRMR -1.64%
LSTA -4.09%
LTRN 1.00%
LUMO -1.32%
LVTX -2.25%
LXEO -3.52%
LXRX -2.65%
LYEL -30.96%
LYRA -1.63%
MACK 0.10%
MBIO -10.26%
MBRX -0.71%
MCRB 6.70%
MDGL -2.58%
MDNA -13.16%
MDWD -0.34%
MDXG -2.36%
MEIP 0.24%
MESO -1.04%
MGNX -4.90%
MGTA -7.74%
MGTX -1.24%
MGX 1.07%
MIRM -1.81%
MIRO 0.59%
MIST 1.53%
MITO 0.00%
MLEC -5.13%
MLECW 2.31%
MLND -5.36%
MLTX -1.32%
MLYS -1.52%
MNKD -1.51%
MNMD -0.39%
MNOV 1.41%
MNPR -4.79%
MOLN -1.65%
MOR 1.06%
MORF -3.28%
MREO -3.86%
MRKR 4.50%
MRNA -4.93%
MRNS -3.31%
MRSN -2.14%
MRTX -0.17%
MRUS -0.12%
MRVI 0.58%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -1.23%
MYMD 2.70%
NAMS 0.66%
NAMSW 0.43%
NAUT 1.99%
NBRV 0.71%
NBSE -1.56%
NBTX 8.03%
NCNA 1.32%
NERV -3.48%
NEXI 2.60%
NGM -1.28%
NGNE -0.66%
NKGN 3.36%
NKGNW 8.00%
NKTR -2.80%
NKTX -3.59%
NLSP -4.39%
NLSPW 26.67%
NMRA -0.06%
NMTR -42.97%
NOVN -24.84%
NRBO 11.97%
NRIX 0.10%
NRSN -9.64%
NRSNW 0.00%
NRXP -8.97%
NRXPW 14.03%
NRXS -4.23%
NTBL 5.04%
NTEC -12.45%
NTHI 0.00%
NTLA -7.54%
NTRBW -31.07%
NUVL -1.43%
NVAX -2.57%
NVCT 0.07%
NVIV -34.28%
NXTC -3.82%
NYMX -0.05%
OABI 0.79%
OABIW -10.06%
OBIO -1.46%
OBSV 0.00%
OCEA -0.70%
OCGN 3.83%
OCS -1.02%
OCUL -3.89%
OCUP 1.95%
ODT -4.27%
OKYO 1.51%
OLMA -4.00%
OMER -2.44%
OMGA 4.16%
ONCO 10.90%
ONCR -3.08%
ONCS 31.87%
ONCT -1.87%
ONCY -0.99%
ONTX -0.47%
ONVO 0.99%
OPNT 0.00%
OPT 0.74%
ORGS -0.09%
ORIC -3.86%
ORMP 14.78%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -1.81%
OVID -1.70%
OYST 0.00%
PALI -0.87%
PASG -1.96%
PBLA -7.50%
PBM -4.13%
PBYI -0.51%
PCSA 1.83%
PCVX -0.26%
PDSB 2.53%
PEPG 2.98%
PGEN -2.10%
PHAR 1.51%
PHAS 0.00%
PHAT -2.55%
PHIO -4.96%
PHIOW 36.47%
PHVS -6.38%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.37%
PLUR 4.35%
PMN 0.00%
PMVP -0.60%
PNT 0.16%
PPBT -2.13%
PRAX 1.60%
PRDS 0.93%
PRLD -3.43%
PROG -3.47%
PROK 1.12%
PRQR 0.60%
PRTA -3.71%
PRTC -0.08%
PRTG 1.95%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -7.65%
PSTX -0.39%
PTCT -1.59%
PTE -0.82%
PTGX -2.49%
PTIXW -5.10%
PULM 2.63%
PXMD 0.00%
PYPD 0.07%
PYXS -0.33%
QLGN 0.00%
QNCX 3.56%
QNRX 0.33%
QSI -11.04%
QSIAW -3.13%
QTTB -5.96%
QURE -0.96%
RAIN -1.63%
RANI 5.08%
RAPT -3.86%
RARE 1.76%
RCKT -5.57%
REGN -1.32%
RENB -4.00%
REPL -1.36%
RETA 0.02%
REUN -0.89%
REVB -6.05%
REVBU 3.46%
REVBW -18.13%
RGLS -3.27%
RGNX -4.87%
RIGL -1.12%
RLAY -4.60%
RLMD 0.67%
RLYB 0.34%
RNA -1.82%
RNAC -4.85%
RNAZ 1.92%
RNXT 4.79%
ROIV -1.52%
ROIVW 4.56%
RPHM 0.31%
RPRX 0.22%
RPTX -2.64%
RUBY 2.70%
RVLP -32.05%
RVMD -1.34%
RVMDW 5.10%
RVNC 0.85%
RVPH 0.25%
RVPHW 1.62%
RXDX 0.09%
RXRX -2.74%
RYTM -4.77%
RYZB 0.02%
RZLT 1.53%
SABS 0.00%
SABSW -11.81%
SAGE 0.09%
SANA -4.61%
SAVA -0.49%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 7.09%
SCPH -0.13%
SCPS 0.00%
SEEL -2.95%
SEER 0.00%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO 0.54%
SGMT 0.48%
SGTX -2.56%
SIOX 22.63%
SLDB -5.23%
SLGL 2.97%
SLN -3.76%
SLNO -2.71%
SLRX 7.29%
SLS -2.14%
SMMT 0.00%
SNDX -1.07%
SNGX 1.70%
SNPX -0.32%
SONN 0.00%
SPPI -0.49%
SPRB 0.91%
SPRC -1.98%
SPRO 0.23%
SRNE -25.00%
SRPT -1.69%
SRRA 0.00%
SRRK -2.48%
SRZN -2.45%
STAB 0.00%
STOK -4.30%
STRO -4.18%
STSA 0.00%
STTK -4.64%
SURF -0.93%
SVRA 1.84%
SWTX -0.44%
SYBX 0.00%
SYRS -1.72%
TALS -0.73%
TARA -8.57%
TARS -1.32%
TBPH 0.42%
TCBP 1.37%
TCDA 0.00%
TCON -3.38%
TCRR 0.00%
TCRT 2.64%
TCRX 0.89%
TECH -0.25%
TENX -1.27%
TERN -4.55%
TFFP -3.52%
TGTX -2.55%
THRX 0.12%
TIL 0.02%
TLC 0.00%
TLSA -2.07%
TNGX -0.97%
TNXP -2.40%
TNYA -5.43%
TPST 0.24%
TRDA -2.71%
TRVI -1.53%
TRVN 1.00%
TSHA -19.88%
TSVT -3.46%
TTNP -4.07%
TVTX -0.50%
TYRA -5.24%
UBX -0.48%
UNCY -3.80%
URGN -2.73%
UTHR -0.38%
VACC 11.36%
VALN -2.68%
VAXX 142.42%
VBIV 0.76%
VBLT -8.77%
VCEL -0.53%
VCNX 9.01%
VCYT -0.62%
VERA -3.34%
VERU 0.70%
VERV -3.25%
VIGL 3.63%
VINC 1.74%
VIR 0.00%
VIRI -3.21%
VIRX 3.24%
VKTX -0.46%
VLON -13.04%
VNDA -1.55%
VOR -3.63%
VRCA -0.36%
VRDN -4.62%
VRNA -0.70%
VRPX 0.40%
VRTX 0.53%
VSTM -3.17%
VTGN -1.20%
VTVT -6.43%
VTYX -2.51%
VXRT -0.16%
VYGR -2.17%
VYNE -3.15%
VYNT 7.78%
WINT -3.24%
WVE -3.88%
XBIO 0.97%
XBIT -2.29%
XCUR 6.28%
XENE -2.08%
XERS 1.19%
XFOR 3.03%
XLO 4.43%
XLRN 0.00%
XNCR -0.31%
XOMA -1.45%
XOMAO 0.36%
XOMAP -0.82%
XRTX -7.04%
YMAB -1.96%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -3.02%
ZNTL -3.93%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2022-07-08 Innoviva Strategic Opportunities Llc Buy 7 598 814 Common Stock
2022-07-07 Tommasi Ruben Sell 39 596 Common Stock
2022-07-11 Tommasi Ruben Sell 150 000 Common Stock
2022-07-11 Tommasi Ruben Sell 98 700 Stock Option (right to buy)
2022-07-11 Tommasi Ruben Sell 50 000 Stock Option (right to buy)
INSIDER POWER
52.71
Last 98 transactions
Buy: 9 607 238 | Sell: 3 128 729

ボリューム 相関

長: 0.20 (neutral)
短: -0.50 (neutral)
Signal:(62.724) Neutral

Entasis Therapeutics 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Entasis Therapeutics 相関 - 通貨/商品

The country flag 0.33
( neutral )
The country flag -0.29
( neutral )
The country flag 0.00
( neutral )
The country flag 0.38
( neutral )
The country flag 0.00
( neutral )
The country flag -0.69
( moderate negative )

Entasis Therapeutics 財務諸表

Annual 2021
収益: $0.00
総利益: $0.00 (0.00 %)
EPS: $-0.996
FY 2021
収益: $0.00
総利益: $0.00 (0.00 %)
EPS: $-0.996
FY 2020
収益: $0.00
総利益: $0.00 (0.00 %)
EPS: $-2.10
FY 2019
収益: $7.00M
総利益: $0.00 (0.00 %)
EPS: $-3.33

Financial Reports:

No articles found.

Entasis Therapeutics Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Entasis Therapeutics

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant pathogens in the United States. Its lead product candidate is sulbactam-durlobactam (SUL-DUR), a novel IV antibiotic that is in Phase III clinical trial for the treatment of pneumonia and bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii. The company also develops Zoliflodacin, a novel orally administered molecule, which is in Phase III clinical trial for the treatment of uncomplicated gonorrhea; ETX0282CPDP, an oral drug that is in Phase I clinical trial for the treatment of urinary tract infections; and ETX0462, a drug candidate from NBP platform that is in pre-clinical stage for the treatment of multidrug-resistant gram-negative infections. The company has a license and collaboration agreement with Zai Lab (Shanghai) Co., Ltd. for the development of durlobactam and SUL-DUR; and collaboration agreement with Global Antibiotic Research and Development Partnership for the development and commercialization of a product candidate zoliflodacin. Entasis Therapeutics Holdings Inc. was founded in 2015 and is headquartered in Waltham, Massachusetts. Entasis Therapeutics Holdings Inc. operates as a subsidiary of Innoviva, Inc.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。

Total Execution Time: 3.261754989624 seconds
Number of API calls: 3
Number of DB calls: 9